市场调查报告书
商品编码
1235931
全球生物保存市场:到 2028 年的预测 - 按产品类型、生物标本、技术、应用、最终用户、地区分类Biopreservation Market Forecasts to 2028 - Global Analysis By Type, By Biospecimen, By Product, By Technology, By Application, By End User and By Geography |
根据 Stratistics MRC 的数据,2022 年全球生物保存市场将达到 20.6 亿美元,预计到 2028 年将达到 85.9 亿美元,预测期内增长 269 亿美元。以復合年增长率增长的 %。
为了保存生物材料,天然植物及其抗菌化合物被用于生物保存过程。 生物保存在医疗保健和食品行业中对于生物材料和食品的长期保存极为重要。
根据美国食品和药物管理局 (FDA) 的数据,该机构在 2017 年批准了 16 种个性化药物,占批准药物总数的 20%。
在预测期内,生物样本库的增加预计将推动生物保存市场的扩张。 例如,美国纽约长老会医院和哥伦比亚大学 Vagueros 内外科于 2020 年 3 月作为哥伦比亚大学和其他研究人员收集、存储和分发生物标本和临床数据的集中存储库。建立了 COVID-19 生物样本库。
据估计,开发能够在室温下保存生物标本的介质解决方案会阻碍全球生物保存行业的发展。 例如,室温样品稳定介质如 DNA Stable 和 RNA Stable 可从 Biomatrica, Inc. 获得。 这些替代品通过降低对冰柜和冰箱的需求来限制市场扩张。
凭藉来自风险投资、政府和家长团体以及患者教育的充足资金,全球生物保存市场的参与者有望从极具吸引力的扩张潜力中受益。. 此外,全球生物保存市场的参与者在中国、巴西、印度、东欧、中东和拉丁美洲等快速发展的新兴国家拥有巨大的机会。 这些地区的经济增长增加了可支配收入,从而增加了人口的购买力。
行业格局在很大程度上受到环境存储技术需求的限制。 例如在美国,疫苗每年可挽救约 300 万人的生命,但冷藏和储存不当会损坏或浪费价值约 2000 万美元的疫苗。 冷冻和解冻造成的组织和细胞损伤是一种常见的副作用,破坏了市场的可持续性。
COVID-19 产生了重大影响,因为製药和生物技术公司的研发工作已经扩展到製造和生产需要生物保存的疫苗。 由于与产品消费减少相关的供需链中断,COVID-19 大流行对生物防腐业务产生了负面影响。 然而,随着冠状病毒病例数量下降而解除限制,对 COVID-19 疫苗和疗法的需求激增,推动了行业的全面增长。
预计再生医学在预测期内将占据最大份额,因为它可以再生、替换和修復因疾病、损伤或衰老而受损的组织和器官。 这些药物可以帮助细胞和组织正常运作,并用于治疗各种退行性疾病,包括皮肤病、神经病、心血管病和骨科疾病。
作为生物保存过程不可或缺的一部分,生物保存介质部分预计在整个预测期内将以有利的复合年增长率增长。 此外,调查、诊断、监测和治疗健康障碍的能力预计将在预测期内推动市场发展,而媒体应用程序的功能和细节将得到增强,使研究人员能够访问和交换研究分析和数据。 .
各种实验室、病理中心和医院的血液和实体组织标本的保存,包括肿瘤和其他组织(如外周血细胞、骨髓、脐带血及其衍生物)的石蜡包埋或冷冻生物标本。由于需求,预计北美地区将在预测期内随着需求的增加而主导市场。
由于生物医学研究的进步和尖端疗法的开发,预计北美在预测期内将实现利润丰厚的增长。 此外,由于需要治疗的慢性病发病率不断上升,该地区的市场占有率得到加强。 预计此类企业将通过增加市场上可用的生物防腐产品的种类来支持增长。 此外,预计在预测期内,美国政府机构和其他生物银行机构将大量采用生物保存技术。
生物保存市场的主要参与者是: Biomatrica, Inc.、Azenta Us, Inc.、Mve Biological Solutions、Biolife Solutions、Labvantage Solutions, Inc.、Taylor-Wharton、Thermo Fisher Scientific, Inc.、Panasonic Corporation、Princetoncryo、X-Therma Inc. p>
2022 年 10 月,Azenta, Inc. 收购了 B Medical Systems S.a r.l. 及其子公司,B Medical Systems S.a r.l. 是一家温控存储和运输解决方案提供商,可在全球范围内提供救生护理。
2022 年 7 月,Cellutions BioStorage 是一家从研究到推出的低温保存库,在印度金奈推出。 它是一家提供全方位服务的生物材料存储和物流供应商,与希望在整个产品生命週期过程中外包供应链管理各个方面的生物製药公司合作。 最近开放的设施拥有 25,000 平方英尺的一流基础设施。
购买此报告的客户将免费获得以下定制之一。
根据产品组合、地理分布和战略联盟对主要参与者进行基准测试
According to Stratistics MRC, the Global Biopreservation Market is accounted for $2.06 billion in 2022 and is expected to reach $8.59 billion by 2028 growing at a CAGR of 26.9% during the forecast period. In order to preserve biological material, natural flora and its antimicrobial compounds are used in the process of biopreservation. In order to maintain biological material or food products for an extended period of time, biopreservation is crucial in the healthcare and food industries.
According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.
Over the forecast period, an increase in biobanks is anticipated to fuel market expansion for biopreservation. For instance, the New York-Presbyterian Hospital and Columbia University Vagelos College of Physicians and Surgeons in the United States established the COVID-19 Biobank in March 2020 as a centralised repository for the collection, storage, and distribution of biological specimens and clinical data for researchers at Columbia University and elsewhere.
The development of media solutions that permit the storage of biospecimens at room temperature is estimated to hamper the expansion of the global biopreservation industry. For instance, room-temperature sample stabilisation media such as DNA Stable and RNA Stable are provided by Biomatrica, Inc. Such alternatives limit market expansion by jeopardising the demand for freezers and refrigerators.
Players in the worldwide biopreservation market might anticipate benefiting from attractive expansion potential if sufficient funding is made accessible from venture capitalists, governments, or parent organisations, coupled with patient education. Additionally, players in the global biopreservation market have a huge amount of opportunity in new and fast-growing countries like China, Brazil, India, Eastern Europe, the Middle East, and Latin America. This is because economic growth in these regions has given the population greater purchasing power because disposable incomes have increased.
The industry landscape is significantly constrained by the need for room temperature storage technologies. In the United States, for instance, vaccines save around 3 million lives a year; however, due to improper refrigeration and storage, vaccines worth about 20 million dollars are damaged or dumped. Tissue or cell damage from freezing and thawing is a common side effect, which is harming the market's sustainability.
Due to the expanded efforts in research and development by pharmaceutical and biotech businesses to produce and manufacture a vaccine that required biopreservation, COVID-19 had a significant impact. Due to the disruption in the supply and demand chains caused by the decline in product consumption, the COVID-19 pandemic had a negative impact on the biopreservation business. However, the demand for the COVID-19 vaccine and treatment medicines surged as a result of the limits being removed as a result of the decrease in coronavirus cases, which fueled the growth of the industry across the board.
During the projection period, regenerative medicines are anticipated to account for the largest share because they can regenerate, replace, and repair tissues and organs that are damaged by disease, injury, or the ageing process. These medications can help cells and tissues function properly and are used to treat a variety of degenerative conditions, including dermatology, neurological diseases, cardiovascular conditions, and orthopaedic situations.
Because it is an integral part of the biopreservation process, the biopreservation media segment is anticipated to rise at a lucrative CAGR throughout the forecast period. Additionally, the ability to investigate, diagnose, monitor, and treat health disorders-which are expected to drive the market in the forecast period-is improved by media apps' increased features and details that enable researchers to access and exchange research analysis and data.
Due to the demand for the preservation of blood and solid tissue specimens, including paraffin-embedded or frozen bio-specimens of tumours and other tissues (like peripheral blood cells, bone marrow, and cord blood and its derivatives), across various research institutes, pathological centres, and hospitals, the demand is expected to increase during the projection period, and the North American region is expected to dominate the market.
Because of the rise in biomedical research and the development of cutting-edge therapeutics, North America is predicted to have lucrative growth over the projection period. Additionally, the region's market presence is strengthened by the increased occurrence of chronic diseases that require therapies. Such operations are anticipated to support growth by expanding the variety of biopreservation products accessible on the market. Moreover, the penetration of biopreservation techniques is expected to increase significantly in the U.S. during the projection period as a result of government agencies and other biobanking institutions.
Some of the key players in Biopreservation market Include: Biomatrica, Inc., Azenta Us, Inc., Mve Biological Solutions, Biolife Solutions, Labvantage Solutions, Inc., Taylor-Wharton, Thermo Fisher Scientific, Inc., Panasonic Corporation, Princetoncryo, X-Therma Inc., Stirling Ultracold.
In October 2022, Azenta, Inc. acquired B Medical Systems S.a r.l and its subsidiaries, a provider of temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe.
In July 2022, Cellutions BioStorage, a research-to-launch Cryopreservation Bank, was inaugurated in Chennai, India. It is a full-service biomaterial storage and logistics provider that works with biopharmaceutical firms looking to outsource all aspects of supply chain management throughout the course of a product's life cycle. The recently-launched facility is spread over 25,000 square feet and has top-notch infrastructure.
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances